Figure 2.
Bex and Cile in vitro antilymphoma activity for different subtypes of TCL cell lines. (A) Cell viability in TCL cells upon Bex, Cile, and Ruxo treatment for 48 hours in the presence of physiological concentrations of THs (n = 5). (B) Apoptosis induction determined by caspase 3 of 7 activation in TCL cells upon the indicated treatments for 48 hours (n = 4). Ruxo = 1 μM, Cile = 3 μM, Bex = 1.5 μM, T3 = 1 nM, T4 = 100 nM. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001 vs THs. Veh, no THs.

Bex and Cile in vitro antilymphoma activity for different subtypes of TCL cell lines. (A) Cell viability in TCL cells upon Bex, Cile, and Ruxo treatment for 48 hours in the presence of physiological concentrations of THs (n = 5). (B) Apoptosis induction determined by caspase 3 of 7 activation in TCL cells upon the indicated treatments for 48 hours (n = 4). Ruxo = 1 μM, Cile = 3 μM, Bex = 1.5 μM, T3 = 1 nM, T4 = 100 nM. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001 vs THs. Veh, no THs.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal